Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

121.07
Delayed Data
As of May 18
 -0.08 / -0.07%
Today’s Change
96.18
Today|||52-Week Range
149.34
+1.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues893.0M861.0M941.0M944.0M
 
 
 
 
 
Cost of Goods Sold62.0M46.0M75.5M64.8M
 
 
 
 
 
Depreciation And Amortization102.0M108.0M183.5M101.5M
 
 
 
 
 
 
Operating ExpensesGross Income729.0M707.0M682.0M777.7M
 
 
 
 
 
General Expenses464.0M459.0M437.7M430.0M
 
 
 
 
 
Research And Development199.0M194.0M249.7M176.5M
 
 
 
 
 
Total Operating Expenses628.0M613.0M696.7M596.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income265.0M248.0M244.3M347.7M
 
 
 
 
 
Extraordinary Charge-58.0M-168.0M-105.0M-67.1M
 
 
 
 
 
Interest Expense On Debt23.0M25.0M25.0M25.5M
 
 
 
 
 
Other Expenses18.0M-2.0M-30.6M-9.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income206.0M58.0M89.3M351.6M
 
 
 
 
 
Income Taxes-41.0M-20.0M-59.3M-102.5M
 
 
 
 
 
Net Income165.0M78.0M30.0M249.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS224.0M223.0M223.3M222.1M
 
 
 
 
 
Shares To Calculate EPS Diluted225.0M225.0M225.0M223.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.73$0.35$0.13$1.11
 
 
 
 
 
EPS Diluted$0.73$0.35$0.13$1.11